Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Clin Oncol (R Coll Radiol). 2005 Dec;17(8):591-8.

    Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments.

    Source

    Clinical Oncology Department, Christie Hospital NHS Trust, Manchester, UK. corinne.finn@christie-tr.nwest.nhs.uk

    Abstract

    Thoracic radiotherapy has an established role in the management of limited-disease small-cell lung cancer (LD SCLC). However, essential questions relating to the optimisation of thoracic radiotherapy remain unanswered, including volume of irradiation, optimal total dose, fractionation, timing and sequencing of radiation. This review highlights the need for well-designed multi-national trials aimed at the optimisation and standardisation of radiotherapy for LD SCLC.

    PMID:
    16372483
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk